2020 Drug Launches, Like Everything, Will Be Remembered For COVID-19

Gilead's Veklury for the treatment of COVID-19 was a clear commercial standout among new drugs in 2020, but cancer drugs like Seagen's Padcev and Tukysa are poised for long-term potential.

scrip perspectives
New drugs faced an uncertain launch environment in 2020 • Source: Shutterstock

Like most things in 2020, new drug launches faced the unexpected consequences of a world weighed down by the pandemic. The outbreak of COVID-19 early in the year led to stay-at-home orders and public health concerns that kept many patients and industry sales reps out of doctor's offices and curtailed non-essential medical procedures, widely impacting the global drug launch environment.

The raging health crisis also demonstrated the resiliency of pharma and the importance of having research-based innovation engines that could...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip